One hundred consecutive female @entity1 with active @entity1252 ( @entity1252 ) were studied from the cardiovascular point of view by means of non invasive methods. Seventy percent of the cases presented some type of @entity854 . Seventy four percent of the resting electrocardiograms were abnormal as well as 72% of the M mode echocardiograms and 55% of the cardiac X ray series. The most frequent observed complications were: @entity2396 and or pericardial effusion (39%), arterial @entity101 (22%), @entity741 (16%), @entity2401 (14%), @entity712 (10%), @entity120 (9%), @entity340 (9%), @entity1143 (7%) and cerebro vascular accident (3%). We analyzed each one of these complications and found of special interest the high incidence of @entity741 which is more frequent than has been hitherto reported. @entity741 was observed in two types of @entity1 : a) Those with long term @entity134 therapy. In these, the mechanism seems to be an @entity731 probably induced by the chronic use of @entity230 . The management of these cases do not differ from other types of @entity301 due to @entity731 . b) Those with frank episodes of @entity1333 in whom the basic mechanism is an inflammatory process of the coronary arteries and its treatment is fundamentally that of the @entity1333 . We consider necessary to study routinely all @entity1 with @entity1252 through non invasive cardiological methods.

Cardiovascular manifestations in XXXX . Prospective study of 100 @entity1 .

@entity1 :: ('9606', 'Species') :: ['patients'] @entity1143 :: ('MESH:D010996', 'Disease') :: ['pleural effusion'] @entity712 :: ('MESH:D006333', 'Disease') :: ['congestive heart failure'] @entity101 :: ('MESH:D006973', 'Disease') :: ['hypertension'] @entity301 :: ('MESH:D003327', 'Disease') :: ['coronary heart disease'] @entity1333 :: ('MESH:D014657', 'Disease') :: ['vasculitis'] @entity2396 :: ('MESH:D010493', 'Disease') :: ['pericarditis'] @entity1252 :: ('MESH:D008180', 'Disease') :: ['SLE', 'systemic lupus erythematosus'] @entity120 :: ('MESH:D006976', 'Disease') :: ['pulmonary hypertension'] @entity134 :: ('CHEBI:35341', 'Chemical') :: ['steroid'] @entity854 :: ('MESH:D018376', 'Disease') :: ['cardiovascular anomaly'] @entity741 :: ('MESH:D017202', 'Disease') :: ['Ischemic heart disease', 'ischemic heart disease'] @entity230 :: ('MESH:D013256', 'Chemical') :: ['steroids'] @entity731 :: ('MESH:D050197', 'Disease') :: ['atherosclerosis', 'atherosclerotic disease'] @entity340 :: ('MESH:D006349', 'Disease') :: ['valvular heart disease'] @entity2401 :: ('MESH:D009205', 'Disease') :: ['myocarditis']
@entity1252 :: (MESH:D008180,Disease) :: ['systemic lupus erythematosus']
